Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Kaufen / Verkaufen

Top-Partner CFD-Broker

Plus500
  • Keine Kommissionen, enge Spreads
  • Hebel- und Long/Short-Trading, fortgeschrittene Analysetools, kostenlose Echtzeitkurse etc.
  • CFD-Trading auf Aktien, Indizes, Krypto, Rohstoffe und Devisen
Direkt zu Plus500 CFD service. Ihr Kapital unterliegt einem Risiko.

Premium-Partner

IG Bank
  • Ein weltweit führender CFD-Anbieter*, FINMA-reguliert
  • Über 17'000 Märkte: Indizes, Devisen, Rohstoffe, Aktien, Kryptowährungen, Optionen und mehr
  • Erweiterte Handelszeiten und Wochenendhandel
  • Schweizer Kundenserviceteam, mit Büros in Genf und Zürich
*Die IG Gruppe ist grösster Anbieter nach Umsatz (veröffentlichter Geschäftsbericht 2022)
Direkt zur IG Bank Verluste können Einlagen übersteigen.
Saxo Bank
  • Lizenzierte Schweizer Bank (FINMA)
  • Keine Depotgebühren bei aktivierter Wertpapierleihe
  • Aktien, ETFs, Optionen, FX, CFDs, Futures, Rohstoffe, Bonds, Mutual Funds - auf einer Plattform
  • Gratis Expertenanalysen und Trading-Signale
  • Saxo Deal: Rückerstattung der Courtagen bis CHF 200 während 90 Tagen
Direkt zur Saxo Bank
Werbung
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
14.01.2025 08:37:43

Recent High-Flyers: Top 10 Short-Term Picks That Skyrocketed!

Chew a
34.20 CHF 0.52%
Kaufen / Verkaufen

(RTTNews) - In 2024, several stocks delivered impressive returns, rewarding intelligent investors with gains as high as 250%. From cutting-edge IoT solutions to innovative biopharmaceuticals, these companies have demonstrated exceptional growth and resilience. Here's how some of our top stock picks have fared in recent months:

1. Verona Pharma plc (VRNA)

Publication Price: $14.80 (June 27, 2024)

Performance Price: $51.80 (Jan 7, 2025)

Gain: 250%

This London, United Kingdom-based clinical-stage biopharmaceutical company Verona Pharma plc (VRNA) tops our list, returning about 250 percent since our alert in June 2024. We profiled the stock on June 27, 2024, when it was trading around $14.80. VRNA hit the 52-week high of $51.80 on January 7, 2025, reflecting an impressive gain of 250 percent from our published price.

Known for its innovative treatments for respiratory diseases, the company's growth was fueled by successful clinical trials and regulatory approvals, positioning it as a prominent player in the healthcare sector.

2. Byrna Technologies Inc. (BYRN)

Publication Price: $11.46 (July 9, 2024)

Performance Price: $31.32 (Dec 26, 2024)

Gain: 173.3%

The other standout performer was the Andover, Massachusetts-based less-lethal self-defense technology company Byrna Technologies Inc. (BYRN), delivering over 173 percent return. We alerted our subscribers to BYRN on July 9, 2024, when it was trading around $11.46. The stock hit a 52-week high of $31.32 on December 26, representing a gain of 173.3 percent from our published price. The notable appreciation in stock value reflects the company's robust financial health and favorable market sentiment.

3. Impinj Inc. (PI)

Publication Price: $92.45 (Jan 17, 2024)

Performance Price: $239.88 (Oct 14, 2024)

Gain: 159.47%

Another stock pick worth mentioning is Impinj Inc. (PI). We alerted this RAIN RFID provider and Internet of Things pioneer to our subscribers on January 17, 2024, when it was trading at around $92.45. The stock reached an all-time high of $239.88 on October 14, 2024, representing a gain of 159.5 percent, thanks to increased adoption of its innovative RAIN RFID technology across various industries.

4. Asana Inc. (ASAN)

Publication Price: $11.64 (June 21, 2024)

Performance Price: $27.77 (December 16, 2024)

Gain: 138.6%

Our alert on Asana Inc. (ASAN) was published on June 21, 2024, when it was trading around $11.64. The stock rose to a 52-week high of $27.77 on December 16, 2024, representing a gain of about 138.6 percent. The increasing adoption of this company's work management platform contributed to its strong performance.

5. Chewy Inc. (CHWY)

Publication Price: $16.75 (March 21, 2024)

Performance Price: $39.10 (June 27, 2024)

Gain: 133.4%

This popular online pet retailer Chewy Inc. (CHWY) was featured on our 'Short-Term Investor' on March 21, 2024, when it was trading at around $16.75. CHWY hit a 52-week high of $39.10 on June 27, 2024, representing a gain of 133.4 percent from our published price. The stock price surge reflects the company's continued expansion in the pet market and strategic partnerships.

6. Powell Industries Inc. (POWL)

Publication Price: $165.17 (July 31, 2024)

Performance Price: $364.98 (November 11, 2024)

Gain: 121%

On July 31, 2024, we identified Powell Industries Inc. (POWL), when the electrical power solutions maker was trading at around $165.17. The stock reached an all-time high of $364.98 on November 11, 2024, up 121 percent from our published price. The Houston, Texas-based company's robust financial performance and strategic initiatives contributed to its growth.

7. Clearwater Analytics Holdings Inc. (CWAN)

Publication Price: $16.50 (May 2, 2024)

Performance Price: $35.71 (Nov 07, 2024)

Gain: 116.4%

SaaS solutions provider Clearwater Analytics Holdings Inc. (CWAN) was profiled on May 2, 2024, when the stock was trading around $16.50. Shares of CWAN reached a 52-week high of $35.71 on November 7, 2024, implying a gain of 116.4 percent from our published price. This Boise, Idaho-based company's SaaS solutions have been well-received in the market, contributing to its impressive performance.

8. Veracyte Inc. (VCYT)

Publication Price: $21.68 (May 8, 2024)

Performance Price: $46.00 (Dec 6, 2024)

Gain: 112.2%

Genomic diagnostics company Veracyte Inc. (VCYT) has returned over 112% since our alert in May 2024. We profiled VCYT on May 8, 2024, when it was trading around $21.68. The stock hit a 52-week high of $46.00 on December 6, 2024, reflecting a gain of 112.2 percent from our published price. The company's strong financial performance and innovative solutions attracted significant investor interest.

9. Hims & Hers Health Inc. (HIMS)

Publication Price: $17.52 (August 6, 2024)

Performance Price: $35.02 (Nov 27, 2024)

Gain: 99.9%

Telehealth platform Hims & Hers Health Inc. (HIMS) was featured on our 'Short-Term Investor' on August 6, 2024, at an opening price of $17.52. HIMS reached an all-time high of $35.02 on November 27, 2024, marking a gain of 99.9 percent from our published price. The impressive growth reflects the increasing adoption of HIMS' telehealth services and a strong financial performance.

10. Revolve Group Inc. (RVLV)

Publication Price: $20.99 (August 7, 2024)

Performance Price: $39.58 (December 17, 2024)

Gain: 88.6%

We alerted our subscribers to this online fashion retailer Revolve Group Inc. (RVLV) on August 7, 2024, at an opening price of $20.99. The stock recorded a 52-week high of $39.58 on December 17, 2024, representing a gain of 88.6 percent from our published price. The rise in consumer spending on fashion and the forte of Revolve's business model contributed to its robust performance.

Conclusion

The year 2024 has demonstrated the significant potential of strategic investments in multi-bagger stocks. Investors who seized these opportunities enjoyed returns of up to 250%. Which of these high-flyers caught your attention, and did you capitalize on any of these opportunities?

Analysen zu Chewy Inc Registered Shs -A-

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

KI gefragt: Aktien für die Ewigkeit – Wall Street Live mit Tim Schäfer

In unserer heutigen Folge spricht Tim Schäfer im Interview mit David Kunz, COO der BX Swiss AG über eine Auswahl an Aktien, welche von einer künstlichen Intelligenz prognostiziert wurden. Diese Titel sind laut KI optimal für ein langfristiges Buy and Hold Portfolio.
Welche Meinung haben Tim Schäfer und David Kunz vom Portfolio und halten diese Titel langfristig stand? Diese und weitere Fragen beantwortet Tim Schäfer in der heutigen Ausgabe von Wall Street Live.

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

KI gefragt: Aktien für die Ewigkeit – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’472.41 19.65 7CSSMU
Short 12’728.20 13.86 U4B7SU
Short 13’213.66 8.88 UIPBSU
SMI-Kurs: 11’990.27 17.01.2025 17:30:19
Long 11’500.00 19.85
Long 11’223.97 13.62 SSSMAU
Long 10’720.07 8.69 SSOMSU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Börse aktuell - Live Ticker

SMI geht mit Gewinnen ins Wochenende -- DAX schliesst höher und knackt erstmals 20'900-Punkte-Marke -- Wall Street schlussendlich stärker -- Asiens Börsen letztlich uneinheitlich

Der heimische Aktienmarkt zeigte sich vor dem Wochenende freundlich und überschritt zeitweise sogar die 12'000-Punkte-Marke. Der deutsche Leitindex setzte seine Rekordrally fort und knackte erstmals die 20'900 Zähler. Die US-Börsen notierten im Freitagshandel mit Gewinnen. Die Börsen in Fernost fanden am Freitag keine gemeinsame Richtung.

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten